Objectives: To evaluate whether a quality improvement intervention reduces sternal wound infection rates in children after cardiac surgery. Design: This is a pre-and postintervention quality improvement study. Setting: A 16-bed cardiac ICU in a university-affiliated pediatric tertiary care children's hospital. Patients: All patients undergoing cardiac surgery via median sternotomy from January 2010 to December 2014 are included. The sternal wound infection rates for primary closure and delayed sternal closure are reported per 100 sternotomies. The hospitalacquired infection records were used to identify preintervention cases, while postintervention cases were collected prospectively. Intervention: Implementation of a sternal wound prevention bundle during the preoperative, intraoperative, and postoperative periods for cardiac surgical cases. Measurements and Main Results: During the preintervention period, 32 patients (3.8%) developed sternal wound infection, whereas only 19 (2.1%) developed sternal wound infection during the postintervention period (p = 0.04). The rates of sternal wound infection following primary closure were not significantly different pre-and postintervention (2.4% vs 1.6%; p = 0.35). However, patients with delayed sternal closure had significantly lower postintervention infection rates (10.6% vs 3.9%; p = 0.02). Conclusions: Implementation of a sternal wound prevention bundle during the perioperative period was associated with lower sternal wound infection rates in surgeries with delayed sternal closure. (Pediatr Crit Care Med 2017; 18:461-468) 
S
urgical site infections (SSIs) are a common postoperative complication in children undergoing cardiac surgery (1, 2) . Risk factors for SSI include: younger age at time of surgery, presence of genetic abnormalities, preoperative hospitalization, ventilatory support, extracorporeal membrane oxygenation (ECMO) use, and delayed sternal closure (DSC) (3) (4) (5) (6) (7) (8) (9) . According to the National Nosocomial Infection Surveillance System and the Center for Disease Control and prevention (CDC), SSI rates vary from 0.5% to 6% following pediatric cardiac surgery (6) (7) (8) (9) .
Prior to 2012, our institution did not have a standardized process for identifying or preventing sternal wound infections (SWIs). An observational analysis revealed inconsistency among surgeons regarding skin antisepsis prior to and during surgery, timing of dressing change postsurgery, and lack of standardized surveillance to identify SWI. We initiated a quality improvement (QI) effort to reduce SWI in all patients undergoing cardiac surgery. A sternal wound prevention bundle (SWPB) was instituted in July 2012. These interventions were multifaceted and recommended for patients of all ages undergoing surgery (10) (11) (12) (13) . The interventions were instituted in three periods of acute surgical care: preoperatively, intraoperatively, and postoperatively (Fig. 1) .
The purpose of the project was to reduce SWI. We describe the QI, SWPB elements, timing of bundle elements implementation, and comparison of SWI rates before and after QI implementation. We also describe the effects of the SWPB on outcomes including mortality and resource utilization in patients with SWI.
METHODS

Setting and Context
All patients undergoing cardiac surgery at a tertiary care center in the Intermountain West between January 1, 2010, and December 31, 2014, were included. We performed an observational analysis of SWI rates for primary closure (PC) and DSC procedures, before and after implementation of a multidisciplinary QI project.
The preintervention period was from January 2010 to June 2012. SWI cases were collected retrospectively. The postintervention period was from July 2012 to December 2014. Data of cases identified postintervention were collected prospectively.
Preintervention
Prior to July 2012, preoperative patients had a regular bath but no other preparation. The first dose of antibiotic was routinely administered during peripheral IV placement with a potential delay between antibiotic administration and time to surgical incision. Subsequent antibiotic doses were administered every 4 hours. Skin antisepsis in the operating room (OR) was surgeon dependent and varied between Hibiclens (Molnlycke Health Care US, LLC, Norcross, GA) and Prevail (Medline Industries, Northfield, IL) solutions. Hair removal was done using razors. Postoperatively, patients with open sternums had dressing changes at least once per day; however, there were no dressing change protocols, and timing was variable. For PC, an occlusive dressing was placed over the incision in the OR; however, time to removal postoperatively was also variable. Postoperatively, chest tubes were immediately placed to wall suction. For patients with open sternums, 10F suction catheters were occasionally placed inside Argyle chest tubes (Benton, Dickinson and Company, Franklin Lakes, NJ) according to surgeon preference and removed once the immediate postoperative bleeding was well controlled. Our institution does not utilize routine nasal screening practices to determine Staphylococcus aureus carrier status.
Planning and Implementing the Study Intervention
In early 2012, a QI team was assembled to evaluate perioperative patient care practices. The team met, reviewed SWPB research, and created a process map to assess current practices utilized for prevention of SWI in children. We identified deficiencies in processes and delineated primary drivers as follows: 1) implementation of a SWPB and 2) need to accurately and promptly diagnose SWI (Fig. 2) .
The QI team assessed previously reported efforts to reduce rates of SWIs in children. The adoption of a SWPB in our hospital is mostly adapted from best adult practices and includes the use of chlorhexidine baths for skin antisepsis both preoperatively and during the operation (12) . In addition, SWPB adopted use of nasal mupirocin ointment to decolonize nasal carriers of methicillin-resistant S. aureus (MRSA) during the preoperative period, as this can be associated with a 2-14-fold increased risk of SSI (14, 15) . Implementation of the SWPB required broad-based provider education as well as support from hospital leadership, cardiothoracic surgery, and providers at all levels and disciplines.
A surveillance system for SWI was implemented in collaboration with the information technology (IT) department. The IT department provided automatic surveillance and distribution of patients with a suspected SWI to the QI team on a weekly basis. The criteria used to identify potential SWI included 
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hospital readmission within 90 days of surgery, patients treated with antibiotics for more than 72 hours after chest closure, and SWI infections identified in the cardiothoracic surgery database. All patients with suspected SWI were reviewed by a multidisciplinary team including a member from infection control team and a cardiac ICU (CICU) nurse practitioner, applied standardized CDC criteria to confirm a case of SWI. All SWIs were presented in scheduled morbidity conferences held by the cardiothoracic surgery, critical care, and cardiology divisions.
The initiative for SWPB was implemented in July 2012 for inpatients undergoing planned cardiac surgery. The outpatient implementation for patients admitted from home started in March 2013.
The Inpatient Preoperative SWPB Intervention. It consisted of nightly chlorhexidine baths and mupirocin nasal ointment twice daily for 2-5 days prior to surgery. The outpatient SWPB intervention included mupirocin and chlorhexidine bath provided to patients during their preoperative outpatient visit with detailed instructions to begin application within 1-3 days of surgery.
The Intraoperative SWPB Interventions. It included skin antisepsis with chlorhexidine (ChloraPrep, Benton, Dickinson and Company) solution and hair removal with clippers for all cardiac surgical patients undergoing sternotomy or thoracotomy. Standardized IV antibiotic doses by weight were administered at the following time points: within 5-60 minutes of the initial surgical incision, with initiation of cardiopulmonary bypass, and every 3 hours intraoperatively for the duration of the case.
Postoperative SWPB. Postoperative SWPB antibiotic duration was standardized to 48 hours after PC or 48 hours after DSC. The occlusive sternal dressing applied at the time of chest closure was removed 48 hours postoperatively. A standardized checklist used during CICU rounds prompts team members to inspect the sternal wound 48 hours postoperatively and daily thereafter. Additionally, a standardized process for bedside care of an open sternum, including timing of dressing changes, sternal closure procedure, and chest tube removal were implemented.
Cohort Identification
All patients with SWI were identified from the hospitalacquired infection (HAI) control database using the CDC criteria of the corresponding year and rate reported per 100 sternotomies. All sternotomies from the corresponding years were reviewed and followed the CDC recommendations for inclusion in the denominator. The SWI cases were divided between PC and DSC. SWI related to DSC followed the same CDC definitions for PC once the sternum was closed. If the sternum was not closed, they were categorized as nonsurgical DSC-other. The SWIs were categorized using the National Healthcare Safety Network (NHSN) definitions from the CDC as superficial, organ space, or nonsurgical site-other/abscess if the infection occurs after open sternotomy and prior to delayed closure. None of the infections were classified as deep because of the lack of deep soft tissue between the skin and the sternum in infants and young children.
For patients with SWI, demographic and clinical data were collected. These included underlying conditions, time from primary surgery to SWI diagnosis, antibiotic use greater than or equal to 4 weeks, length of hospitalization to treat infection, microorganism cultured from the sternal wound, and whether bacteremia was present.
Evolution of the Interventions
Several Plan-Do-Study-Act cycles were instituted to facilitate and monitor compliance. A checklist was used during CICU rounds to prompt initiation of chlorhexidine baths and mupirocin nasal ointment administration 2-5 days prior to surgery. Later, preprinted admission orders included mupirocin and chlorhexidine baths for all preoperative cardiac patients. Biweekly safety rounds reminded providers to initiate preoperative SWPB. Date and time of mupirocin dispensing from the inpatient pharmacy were tracked. Due to the multidose nature of mupirocin, it was difficult to track daily nursing compliance with administration for inpatients in the CICU. Compliance to preoperative chlorhexidine baths was audited from bedside nursing documentation.
Intraoperative compliance to the SWPB during the postintervention period was assessed using routine OR audits for both the use of chlorhexidine for skin antisepsis and the timing of IV antibiotic administration.
Postoperatively, reminders to inspect the sternal incision and to remove sternal dressings 48 hours following closure were placed on bedside computers and on the rounds checklist. A preprinted postoperative admission order set provided standardization of antibiotic administration.
Surveillance for SWI was assessed by ICU staff members including physicians, nurse practitioners, and nursing staff daily. Evaluation of patients with concerns for SWI included a sternal wound culture, blood culture, and an infectious disease consultation whenever possible.
Measures
Primary outcome measures included SWI rates per 100 sternotomies for patients undergoing either PC or DSC before and after implementation of the SWPB. Process measures included compliance with SWPB elements.
For balancing measures, we used resource utilization of patients with SWI measured as the proportion of patients requiring at least one surgical debridement, wound vacuumassisted closure (VAC), use of peripherally inserted central catheter (PICC) for antibiotic administration, the proportion of patients treated with antibiotics for more than or equal to 4 weeks, and post-SWI hospital length of stay (HLOS). "HLOS" was defined as the length of inpatient hospitalization to treat a SWI. If a patient was an inpatient before SWI diagnosis, the HLOS was tabulated from date of primary surgery to home discharge. We included mortality to discharge and ECMO use comparing pre-and postintervention periods
Statistical Analysis
Summary statistics are presented as means with sd or median values with interquartile ranges (IQRs). Continuous data were analyzed using Mann-Whitney U test or an independent t test, whereas categorical data were evaluated using a chi-square test or Fisher exact test. Statistical significance was defined as p value of less than 0.05. All data were analyzed using SPSS 23.0 for Windows (SPSS, Chicago, IL) and Epi-info (Centers for Disease Control and Prevention, Atlanta, GA) to compare features in the two patient groups.
Ethical Considerations
The study was approved and a waiver of informed consent granted by the University of Utah Institutional Review Board and Primary Children's Hospital Private Board. A total of 51 patients were identified with SWI during the study periods, 32 cases in the preintervention group and 19 cases in the postintervention group (p = 0.04). The relative risk (RR) of a patient having a SWI before the SWPB implementation was 1.8 times greater than after implementation (95% CI, 1.02-3.13). Sixty patients need to be treated with SWPB for one SWI to be prevented.
RESULTS
Population Description of Entire Cohort
Preintervention Versus Postintervention Groups
Demographic and clinical characteristics for the pre-and postintervention groups are summarized in Table 1 . Baseline characteristics including weight, proportion of patients with single ventricle physiology, and complexity of surgical cases using Risk Adjustment for Congenital Heart Surgery score were similar between Preoperative compliance for mupirocin was difficult to track. Mupirocin was dispensed in 100% of patients; however, compliance regarding administration by nursing staff could not be readily verified due to the multidosing nature of the medication packaging. Preoperative chlorhexidine compliance reached 70% in the postintervention group as documented by the bedside nursing flowsheet. Postintervention compliance for the intraoperative use of chlorhexidine skin antisepsis and intraoperative antibiotic administration reached 100%, as did timing and duration of postoperative antibiotic. This is likely attributable to dedicated OR staff, routine screening and auditing of cases by cardiac anesthesia, pharmacy participation in daily rounds, and the use of preprinted order sets at the time of CICU admission after surgery.
Balancing Measures: Resource Utilization. Table 4 shows resource utilization of patients with SWI by study period. SWI accounted for over 3 weeks of hospital days (median, 22 d) and did not differ between study periods. Likewise, the proportion of patients who remain hospitalized after surgery when SWI was diagnosed, PICC line use, antibiotics greater than or equal to 4 weeks and the fraction treated with surgical debridement, was similar in both groups. However, use of VAC was over twice as common in the postintervention group (RR, 2.4; 95% CI, 1.1-5.3), the HLOS of SWI patients treated with and without VAC (50 vs 20 d; p = 0.08) was not different.
Among SWI patients, mortality was similar across the preand postintervention periods (3% vs 10%; p = 0.14). During the preintervention period, two patients (6%) received ECMO compared to one patient (5%) in the postintervention group. Neither SWI nor sepsis was the direct cause of death for any patient during the study period.
DISCUSSION
We report SWI rates both before and after the implementation of a SWPB in children undergoing cardiac surgery. The use of a SWPB in pediatric cardiac patients resulted in both a standardization of the perioperative care to prevent SWI as well as a significant reduction in SWI rates in patients with DSC.
Because best practices have not been established for infants and children, we emulated care of adult patients modified by data from pediatrics when available (10) (11) (12) (13) . We found that compliance with the recommended number of chlorhexidine baths and mupirocin nasal ointment was difficult among critically ill neonates and not optimal compared to the other compliance elements. This was due in part to variability in the preoperative days and the unique medical record system of our institution.
Our results differ slightly from those reported by Adler et al (10) , who also implemented SWPB and reported significantly decreased rates of SWI for both PC and DSC procedures. However, our study found a significant decrease in SWI by DSC. Although DSC is often used to mitigate postoperative hemodynamic and respiratory instability in select patients, it can be associated with postoperative morbidity, mortality, and prolonged HLOS (16) . Because the integument is violated, it is not surprising that DSC, which is primarily used in critically ill neonates, is an important risk factor for SWI (16) . Our SWI rates following DSC are difficult to compare to previously reported data because the definition of SWI in DSC patients has changed. Prior to 2016, the CDC's NHSN surveillance of SSI did not include infections occurring after DSC. In addition, definitions of SWI infections changed in 2013 and reduced the duration of surveillance from 1 year to 90 days for procedures utilizing prosthetic materials. It is possible that the 2013 definition excluded patients previously identified as SSI; however, readmission after cardiac surgery in our institution is consistently captured in the cardiothoracic surgery database. Applying the NHSN classification, a higher proportion of patients had an organ occupying space infection in the preintervention while a higher proportion of superficial infections occurred in the postintervention period. The present study reports lower SWI rates caused by Staphylococcal species in the postintervention group (42% vs. 60%); however, MRSA contributed to 10% of those infections. During the preintervention period, the most predominant organisms cultured from sternum were MSSA and CoNS with no cases of MRSA. This could be due in part to the emergence of MRSA in the general population and the increasing bacterial resistance of S. aureus to mupirocin during the postintervention period (17) . This is an important finding, as MRSA is associated with higher mortality rates, longer HLOSs, and higher hospital costs compared with other infections (18) . Despite these findings, there is still a high proportion of SWI in our cohort that was either culture negative or no culture sent, although clinical findings demonstrated a significant SWI.
Not surprisingly, the SWI patients entailed high resource utilization. Surgical use of VAC increased more than two-fold in the postintervention period, although HLOS did not differ when comparing pre-and postintervention groups or HLOS of SWI patients treated with and without VAC. Although more than half of the SWI infections in the postintervention period were classified as superficial, a high proportion had surgical debridement and VAC application. VAC dressings are used in the treatment of post sternotomy mediastinitis and works by increasing peristernal blood flow, leading to enhanced granulation tissue formation. At the same time, VAC treatment assists in facilitating wound edge approximation and stabilization of the chest (19) .
This study has some important limitations. Due to our unique electronic medical record, compliance to the SWPB cannot be easily tracked. This is especially evident with mupirocin multiuse ointment and chlorhexidine baths that do not require scanning from pharmacy prior to administration. Furthermore, prior to 2012, the infection control department in our institution worked independently and had limited interaction with both the CICU and cardiothoracic surgery teams. Following this QI initiative, increased collaboration between infection control, the CICU, and cardiothoracic surgery made surveillance of SWI in postoperative cardiac patients more consistent between groups. It is possible that the infections reported to HAI prior to 2012 may have been under or overestimated due to changes in both the surveillance and CDC SWI definitions during that period. The CDC guidelines were strictly followed to create hospital-wide baseline rates that could be followed and compared over time.
CONCLUSIONS
Implementation of SWPB in patients undergoing cardiac surgery resulted in a significant and clinically important reduction in SWI rates in children undergoing procedures with DSC. This QI process demonstrates the importance of SWPB in the prevention of postoperative SWIs and the collaborative effort of a multidisciplinary team at different stages of the patient's hospitalization.
